-
Location
-
395 Oyster Point Blvd., Suite 217, South San Francisco, CA
-
Summary
-
The estimated net worth of Samuel C. Blackman is at least $29.4M dollars as of December 12, 2024. Samuel C. Blackman is the HEAD OF R&D of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $29.4M.
-
Signature
-
/s/ Charles N. York II, as Attorney-in-Fact